Sign inJoin waitlistJoin the waitlist

CS

Carlos Santos-Gallego

Physician · Icahn School of Medicine at Mount Sinai

Credentials: · ·

History

Icahn School of Medicine at Mount Sinai
Present

Research

Empagliflozin Ameliorates Adverse Left Ventricular Remodeling in Nondiabetic Heart Failure by Enhancing Myocardial Energetics
Journal of the American College of Cardiology · 2019 · First of 12 authors · Corresponding · 556 citations
Randomized Trial of Empagliflozin in Nondiabetic Patients With Heart Failure and Reduced Ejection Fraction
Journal of the American College of Cardiology · 2021 · First of 24 authors · 420 citations
Mechanistic Insights of Empagliflozin in Nondiabetic Patients With HFrEF: From the EMPA-TROPISM Study
JACC Heart Failure · 2021 · 228 citations

Juan Badimon
70 papers
Valentin Fuster
19 papers
AS
Angel Sanz Salvo
13 papers
Roger Hajjar
13 papers
Anuradha Lala-Trindade
6 papers
AC
Anderly Cordero
5 papers · 5 as a resident
DM
Donna Mancini
5 papers
Farah Atallah-Lajam
4 papers
Jacob Koruth
4 papers
Vivek Reddy
4 papers
Icilma Fergus
3 papers
Johanna Contreras
3 papers

Clinical trials

Sotagliflozin as Prevention of Anthracycline-Related Cardiotoxicity
Principal investigator · Not yet recruiting · Phase 2
Icahn School of Medicine at Mount Sinai
2026–2029
ERTU-SODIUM: Study on the Effects of Ertugliflozin on Sodium Storage, Interstitial Volume, and Plasma Volume in HFrEF
Principal investigator · Completed · Phase 4
Icahn School of Medicine at Mount Sinai
2023
Sotagliflozin in Heart Failure With Preserved Ejection Fraction (HFpEF) Patients
Principal investigator · Completed · Phase 4
Juan Badimon
2022–2025